Navigation Links
Pharmacyclics, Inc. Prices Public Offering of Common Stock
Date:3/8/2013

SUNNYVALE, Calif., March 8, 2013 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC), a clinical stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases, today announced the pricing of a previously announced underwritten registered public offering of 2,200,000 shares of its common stock, representing approximately 3.1% of the shares of common stock currently outstanding, at a public offering price of $94.20 per share. All of the shares are being sold by Pharmacyclics. The offering is expected to close on March 13, 2013, subject to customary closing conditions.

J.P. Morgan Securities LLC is acting as sole manager for the offering. Pharmacyclics has granted the underwriter a 30-day option to purchase up to an additional 330,000 shares of common stock to cover over-allotments, if any.

Pharmacyclics intends to use the net proceeds from this offering to accelerate commercial readiness for Ibrutinib post Breakthrough Therapy Designation, to advance its clinical pipeline, including expanding clinical development of Ibrutinib in additional indications, to evaluate strategic opportunities to potentially add synergistic assets, and for general corporate purposes.

The shares will be issued pursuant to an automatic shelf registration statement on Form S-3 previously filed with the Securities and Exchange Commission, Registration No. 333-187104. A preliminary prospectus supplement related to the offering has been filed with the Securities and Exchange Commission. A final prospectus supplement related to the offering will be filed with the Securities and Exchange Commission.

This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Pharmacyclics, nor shall there be any offer or sale
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
2. Inovio Pharmaceuticals Prices $15.1 Million Offering of Common Stock and Warrants
3. Novelos Therapeutics Prices $5.5 Million Public Offering
4. Accuray Prices Offering Of $100 Million Of 3.50% Convertible Senior Notes
5. Volcano Corporation Prices Offering Of $400 Million 1.75% Convertible Senior Notes Due 2017
6. Cynosure, Inc. Prices Public Offering of Class A Common Stock
7. Isis Pharmaceuticals Prices Offering of $201.25 Million of 2 3/4% Convertible Senior Notes, Including Exercise in Full of Over-Allotment Option
8. Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
9. MAP Pharmaceuticals, Inc. Prices Public Offering of Common Stock
10. Omeros Prices $30 Million Public Offering of Common Stock
11. Novelos Therapeutics Prices $5.4 Million Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... York , August 4, 2015 ... titled " Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, ... Others) - Global Industry Analysis, Size, Volume, Share, Growth, ... According to a new market report published by Transparency ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ...
(Date:8/4/2015)... Aug. 4, 2015 BioElectronics Corporation (OTC ... Musculoskeletal Pain Therapy medical devices, announced today that ... ActiPatch 7-day trial device has been published in ... Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 ... submitted an assessment.  Chronic pain ...
(Date:8/4/2015)... DUBLIN , Aug. 4, 2015 Research ... of the "Alcohol Ethoxylate Market by Application (Household ... Geographies Global Market Trends, Forecasts to 2019" report ... of alcohol ethoxylate was valued at $5,124.9 million in ... of about 3.5% from 2014 to 2019. The data ...
Breaking Medicine Technology:Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 4Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 5BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 3
... Regenerate Skeletal Muscle More,Efficiently than Male Cells, PITTSBURGH, April ... have a greater ability to regenerate skeletal,muscle tissue than ... Pittsburgh of UPMC. , The study, which is being ... Cell Biology, is the first ever to report a ...
... 10, 2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences Incorporated announced data ... pipeline, including its Hsp90,inhibitor, epothilone and nuclear export ... American Association for Cancer Research,(AACR), being held in ... on Kosan's programs are as follows. The,location for ...
Cached Medicine Technology:The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 2The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 3Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 2Kosan Announces Data Presentations at Upcoming AACR Annual Meeting 3
(Date:8/5/2015)... ... 2015 , ... A leader in Primary Care Continuing Medical Education (CME), ... Su Barnwell as its new Director of Program Management. , Su has over 16 ... worked for Primary Care Network (PCN) as the Director, Program Implementation as well as ...
(Date:8/5/2015)... ... 05, 2015 , ... As the nation’s premier nonprofit organization ... support in order to reduce the incidence of brain aneurysms and improve outcomes ... has awarded the most funding in the 20-year history of the organization. , ...
(Date:8/5/2015)... ... August 05, 2015 , ... The President of Wisdom Natural ... of this year’s 50 Most Influential Women in Arizona by AZ Business Magazine. ... long-standing dedication to the well-being of consumers through Wisdom Natural Brands’ groundbreaking products ...
(Date:8/4/2015)... ... ... review site BestMillionaireDatingSites.com recently refreshed its list of the top dating platforms for wealthy ... service in the segment. , A representative from the site said, “You certainly cannot ... right dating platform so that they can make the most of it and find ...
(Date:8/4/2015)... ... August 04, 2015 , ... How cool is it ... inspires you via geolocation? The new "Now" feature will soon allow you to do ... able to inspire each other using the now feature. , Users will soon get ...
Breaking Medicine News(10 mins):Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 2Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 4Health News:Carol May Named One of the Most Influential Woman in Arizona 2Health News:Carol May Named One of the Most Influential Woman in Arizona 3Health News:Carol May Named One of the Most Influential Woman in Arizona 4Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2Health News:Ahhaa App Soon to Release the "Now" Feature 2
... could offer new treatments for other autoimmune disorders, study ... believe they have finally answered a basic question about ... body does the wheat protein gluten enter one,s system? ... Gastroenterology identifies the CXCR3 receptor in the ...
... July 24 Tepha, Inc., a developer of,medical ... polymers, announced,today that it has appointed John Hartnett ... Chief Operating Officer. Mr. Hartnett joins Tepha,following an ... he,progressed from field sales, to marketing management, and, ...
... (Becton,Dickinson and Company) (NYSE: BDX ) today reported ... quarter ended June 30, 2008,representing an increase of 14.5 ... rate reflects the favorable impact on all segments,from foreign ... 7 percentage points of the increase in quarterly revenues., ...
... Cancellations and Higher Operating Costs to Affect ... ... 7, 2008, DENVER, July 24 Air Methods Corporation,(Nasdaq: ... an update on second quarter 2008 results., Based on preliminary ...
... alliance of animal,lovers is attacking one of America,s most ... America is struggling with a weight problem. About ... Unfortunately, our pets -- they really,do look like us ... Campaign to End Obesity, a public/private partnership that includes,Harvard ...
... for its module cleanrooms. The feature is a utility panel ... cleanroom appearance. , ... Burnsville, Minn. (PRWEB) July 24, ... systems, announced today that they are now offering a utility panel ...
Cached Medicine News:Health News:Intestinal Gluten Receptor Is Gateway for Celiac Disease 2Health News:Tepha Announces Appointment of John Hartnett as Executive Vice President and Chief Operating Officer 2Health News:BD Announces Results for Third Fiscal Quarter 2Health News:BD Announces Results for Third Fiscal Quarter 3Health News:BD Announces Results for Third Fiscal Quarter 4Health News:BD Announces Results for Third Fiscal Quarter 5Health News:BD Announces Results for Third Fiscal Quarter 6Health News:BD Announces Results for Third Fiscal Quarter 7Health News:BD Announces Results for Third Fiscal Quarter 8Health News:BD Announces Results for Third Fiscal Quarter 9Health News:BD Announces Results for Third Fiscal Quarter 10Health News:BD Announces Results for Third Fiscal Quarter 11Health News:BD Announces Results for Third Fiscal Quarter 12Health News:BD Announces Results for Third Fiscal Quarter 13Health News:BD Announces Results for Third Fiscal Quarter 14Health News:BD Announces Results for Third Fiscal Quarter 15Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 2Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 3Health News:Air Methods Provides 2nd Quarter Update and Date of Quarterly Conference Call 4Health News:PetFit Challenge Helps Keep Pets - and Pet Owners - Healthy 2Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2
... Topical, Bactericide, Microbicide for professional degerming, ... in skin disinfectants combining quaternary and ... synergistic blend of emollients and surfactants. ... gram-positive organisms tested in 30 seconds. ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
... multi-purpose topical solution is for ... Prep Spray is labeled for ... of cross contamination. The controlled ... method to the final step ...
... two and four ounce bottles ... the needs of procedural kit ... itself has been custom molded ... the cap perfectly. This product ...
Medicine Products: